Skip to content
Link copied to clipboard
Link copied to clipboard
Exclusive to subscribersYou can now gift articles

Alzheimer’s drug that modestly slows disease OK’d by FDA

U.S. health officials approved a closely watched Alzheimer’s drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and doctors will have to weigh.